Intensity-Modulated vs. Conventional Radiation Therapy for Anal Cancer
Does Primary Tumor Location Affect Survival in RAS-Mutant Colorectal Cancer?
Novel Approach to Forecasting Response to Cetuximab in Colorectal Cancer
Reduced-Dose Combination Therapy in Geriatric Patients With Metastatic Colorectal Cancer
How Accurate Are NCDB Comorbidity Assessments in Colorectal Cancer and Other Resected Tumors?
Are Outcomes Better in Patients Receiving FIT-Based Colorectal Cancer Screening?
TAILOR Trial: FOLFOX Plus Cetuximab in RAS Wild-Type Colorectal Cancer
Helicobacter Pylori and Colorectal Cancer Risk Among Diverse Populations
Perspectives on Key Questions and Emerging Research in the Management of Gastrointestinal Cancers
Selecting Cancer Treatment: The Role of Tumor Molecular Profiling and Liquid Biopsy
Checkpoint Inhibitors in Gastrointestinal Tumors: The Latest Evidence on Safety, Efficacy, and Biomarkers
Novel and Emerging Strategies in the Management of Gastrointestinal Cancers
University of Wisconsin Carbone Cancer Center
Roswell Park Comprehensive Cancer Center
University of Nebraska
City of Hope
Nivolumab (Colorectal Cancer)
Vemurafenib Triple Regimen
American Society for Gastrointestinal Endoscopy
NCCN Guidelines for Patients®
Colorectal Cancer Alliance